Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

about

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Item

http://www.wikidata.org/entity/Q38626233

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

@en

type

Item

label

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

@en

prefLabel

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

@en

P1476

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

@en

P2093

A Pines

http://www.w3.org/2001/XMLSchema#string

D F Archer

http://www.w3.org/2001/XMLSchema#string

H N Hodis

http://www.w3.org/2001/XMLSchema#string

J A Simon

http://www.w3.org/2001/XMLSchema#string

J H Pickar

http://www.w3.org/2001/XMLSchema#string

P M Sarrel

http://www.w3.org/2001/XMLSchema#string

R A Lobo

http://www.w3.org/2001/XMLSchema#string

W H Utian

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Increased cardiovascular mortality after early bilateral oophorectomy

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13697137.2017.1362156

http://www.w3.org/2001/XMLSchema#string

P50

Robert D. Langer

P577

2017-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28805475

http://www.w3.org/2001/XMLSchema#string